Edwards Lifesciences Corp Sample Contracts

EXHIBIT 10.17 OPTION AGREEMENT
Option Agreement • March 20th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
AutoNDA by SimpleDocs
and
Rights Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research
EXHIBIT 10.22 CONTRIBUTION AGREEMENT
Contribution Agreement • August 11th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
EXHIBIT 2 SHAREHOLDERS AGREEMENT
Shareholders Agreement • April 5th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
CONFORMED COPY AMENDED AND RESTATED 364-DAY CREDIT AGREEMENT
364-Day Credit Agreement • May 15th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
DRAFT: FEBRUARY 14, 2000 ----- REORGANIZATION AGREEMENT Dated as of March 15, 2000 by and between BAXTER INTERNATIONAL INC.
Reorganization Agreement • February 18th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Edwards Lifesciences Corporation and Equiserve Trust Company, N.A. as Rights Agent Rights Agreement Dated as of March 31, 2000
Rights Agreement • May 15th, 2003 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Delaware

RIGHTS AGREEMENT, dated as of March 31, 2000 (the "Agreement"), between Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), and Equiserve Trust Company, N.A., a federally chartered trust company (the "Rights Agent").

EXHIBIT 10.4 CHANGE-IN-CONTROL SEVERANCE AGREEMENT Edwards Lifesciences Corporation April 2000 CONTENTS
Change-in-Control Severance Agreement • March 27th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research
BY AND BETWEEN
Tax Sharing Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
EXHIBIT 2.1 =================================================================== ============= AMENDED AND RESTATED ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • September 15th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.18 JAPAN DISTRIBUTION AGREEMENT dated as of April 1, 2000
Distribution Agreement • March 20th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Exhibit 10.5 Employment Agreement for Michael A. Mussallem Edwards Lifesciences Corporation March 2000 Contents
Employment Agreement • March 15th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Delaware
EXHIBIT 1 SECURITIES PURCHASE AGREEMENT by and between EDWARDS LIFESCIENCES CORPORATION, PLC SYSTEMS INC.
Securities Purchase Agreement • April 5th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
EDWARDS LIFESCIENCES CORPORATION (a Delaware corporation) $600,000,000 4.300% Senior Notes due 2028 UNDERWRITING AGREEMENT Dated: June 6, 2018
Underwriting Agreement • June 7th, 2018 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
ARTICLE I DEFINITIONS -----------
Tax Sharing Agreement • February 18th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
RELATING TO
Option Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
EXHIBIT 10.18 JAPAN DISTRIBUTION AGREEMENT dated as of April 1, 2000 by and between BAXTER LIMITED
Distribution Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Chief Executive Officer Change-in-Control Severance Agreement Edwards Lifesciences Corporation As Amended and Restated March 30, 2009
Change-in-Control Severance Agreement • May 8th, 2009 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies

THIS AMENDED AND RESTATED CHIEF EXECUTIVE OFFICER CHANGE-IN-CONTROL SEVERANCE AGREEMENT (the "Restated Agreement") is made, entered into, and is effective this 30th day of March, 2009 (hereinafter referred to as the "Effective Date"), by and between Edwards Lifesciences Corporation (the "Company"), a Delaware corporation, and Michael A. Mussallem (the "Executive").

FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreement • February 27th, 2012 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware

This Indemnification Agreement, dated as of (this "Agreement"), is entered into by and between Edwards Lifesciences Corporation, a Delaware corporation (together with its subsidiaries, the "Company"), and (the "Indemnitee").

AutoNDA by SimpleDocs
Separation Agreement Between Edwards Lifesciences Corporation and Stuart L. Foster
Separation Agreement • May 9th, 2008 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California

This Agreement, (the "Agreement") is entered into by and between Edwards Lifesciences Corporation (together with its subsidiaries and affiliates, "Edwards") and Stuart L. Foster, Corporate Vice President, Critical Care and Vascular, of Edwards ("Executive").

Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program Global Restricted Stock Unit Award Agreement
Global Restricted Stock Unit Award Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware

THIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms related to a change in control (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Restricted Stock Unit Statement attached to the front of this agreement (the “Statement”) sets forth the terms and conditions of the restricted stock unit (the “RSU”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”

Amended and Restated Employment Agreement for Michael A. Mussallem Edwards Lifesciences Corporation March 30, 2009
Employment Agreement • May 8th, 2009 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Restated Agreement") is made, entered into, and is effective as of the 30th day of March 2009 (the "Effective Date"), by and between Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), and Michael A. Mussallem (the "Executive").

FIVE YEAR CREDIT AGREEMENT dated as of July 15, 2022 among EDWARDS LIFESCIENCES CORPORATION, as a Borrower CERTAIN SUBSIDIARIES, as Borrowers BANK OF AMERICA, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A., as Syndication Agent MORGAN STANLEY...
Five Year Credit Agreement • July 21st, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York

FIVE YEAR CREDIT AGREEMENT dated as of July 15, 2022, among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the “Company”); the other US BORROWERS (as defined herein); the SWISS BORROWERS (as defined herein); the JAPANESE BORROWERS (as defined herein); the SINGAPORE BORROWERS (as defined herein); the ADDITIONAL FOREIGN BORROWERS (as defined herein) (the Company, the other US Borrowers, the Swiss Borrowers, the Japanese Borrowers, the Singapore Borrowers and the Additional Foreign Borrowers being collectively called the “Borrowers”); the LENDERS from time to time party hereto; and BANK OF AMERICA, N.A., as Administrative Agent.

Edwards Lifesciences Corporation Restricted Stock Agreement
Restricted Stock Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies

You have been selected to be a Participant in the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:

Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program Global Nonqualified Stock Option Award Agreement
Global Nonqualified Stock Option Award Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware

THIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Stock Option Statement attached to the front of this agreement (the “Statement”), sets forth the terms and conditions of the nonqualified stock option (the “Option”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”

WITNESSETH:
Tokumei Kumiai Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research
Restricted Stock Units Agreement
Restricted Stock Units Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies

THIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Restricted Stock Units by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.

Form of [Amended and Restated] Change-in-Control Severance Agreement Dated [ ] by and between EDWARDS LIFESCIENCES CORPORATION and
Change-in-Control Severance Agreement • November 7th, 2012 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California

THIS [AMENDED AND RESTATED] CHANGE-IN-CONTROL SEVERANCE AGREEMENT (this “Agreement”) is made, entered into, and is effective as of [ ] (hereinafter referred to as the “Effective Date”), by and between EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the “Company”), and [ ] (the “Executive”).

Change-in-Control Severance Agreement between Edwards Lifesciences Corporation and Effective July 10, 2008
Change-in-Control Severance Agreement • March 2nd, 2009 • Alliance HealthCare Services, Inc. • Orthopedic, prosthetic & surgical appliances & supplies

THIS CHANGE-IN-CONTROL SEVERANCE AGREEMENT is made effective as of the day of (hereinafter referred to as the "Effective Date"), by and between Edwards Lifesciences Corporation (the "Company"), a Delaware corporation, and (the "Executive").

SECOND AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 27, 2003 among EDWARDS LIFESCIENCES CORPORATION as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK as Administrative Agent CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND...
364-Day Credit Agreement • May 15th, 2003 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York

SECOND AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 27, 2003 (this "Amendment and Restatement"), in respect of the 364-DAY CREDIT AGREEMENT dated as of March 30, 2000, as amended through the date hereof (the "Existing Credit Agreement"), among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the "Company"); the LENDERS from time to time party hereto; JPMORGAN CHASE BANK, as Administrative Agent; CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK, N.A., as Co-Syndication Agents and THE BANK OF NOVA SCOTIA AND BANK OF AMERICA, N.A., as Co-Documentation Agents.

AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 28, 2002 among EDWARDS LIFESCIENCES CORPORATION as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK as Administrative Agent CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK,...
364-Day Credit Agreement • May 13th, 2002 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York

AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 28, 2002 (this "Amendment and Restatement"), in respect of the 364-DAY CREDIT AGREEMENT dated as of March 30, 2000, as amended and restated as of March 29, 2001 (the "Existing Credit Agreement"), among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the "Company"); the LENDERS from time to time party hereto; JPMORGAN CHASE BANK, as Administrative Agent; CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK, N.A., as Co-Syndication Agents and THE BANK OF NOVA SCOTIA AND BANK OF AMERICA, N.A., as Co-Documentation Agents.

MASTER AGREEMENT
Master Agreement • June 6th, 2005 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California

This MASTER AGREEMENT (this “Agreement”) is made and entered into as of this 2nd day of June, 2005, by and between Edwards Lifesciences PVT, Inc., a Delaware corporation (“Edwards”), and 3F Therapeutics, Inc., a Delaware corporation (“3F Therapeutics” and, together with Edwards, are each referred to herein as a “Party” and collectively as the “Parties”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!